 | Up a level |
2022
Huober, J., Janni, W., Untch, M., Blohmer, J-U., Zahm, D-M., Hanusch, C., Jackisch, C., Heinrich, G., Schneeweiss, A., Denkert, C., Link, T., Rhiem, K. E., Furlanetto, J., Solbach, C., Klare, P., Nekljudova, V., Filmann, N. and Loibl, S. (2022). Long-term survival of a randomised, open-label, phase II study comparing the efficacy and safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE). Ann. Oncol., 33 (7). S. S615 - 1. AMSTERDAM: ELSEVIER. ISSN 1569-8041
2019
Filmann, N., Walter, D., Schadde, E., Bruns, C., Kecks, T., Lang, H., Oldhafer, K., Schlitt, H. J., Schoen, M. R., Herrmann, E., Bechstein, W. O. and Schnitzbauer, A. A. (2019). Mortality after liver surgery in Germany. Br. J. Surg., 106 (11). S. 1523 - 1530. HOBOKEN: WILEY. ISSN 1365-2168